Rosuvastatin

CAS 287714-41-4 11 current records 1 historicalSmall Molecule

Who holds supplier records for Rosuvastatin? 11 organisations hold a current record for Rosuvastatin: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 1 of them holds a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (6), India (1), United States (1), Netherlands (1) and 1 other country (1); not recorded for 1.

Most records are filed under another form of this substance: Rosuvastatin Calcium (44 current sources). A DMF or CEP is listed under the form it names.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Rosuvastatin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/rosuvastatin

Reading the evidence

  • 11 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in China

    6 of the 10 current records with a recorded country list China. Organisation country is not necessarily the manufacturing site.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (11)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Rosuvastatin. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • ZHEJIANG LEPU PHARMACEUTICAL CO., LTD.
    Active DMF 25781, 20751 · latest filing Feb 2012
    China
  • Jiangsu Alpha Group Furui Pharmaceutical (Suqian) Co., Ltd.
    Active DMF 41439 · latest filing Mar 2025
    China
  • Jiangsu Alpha Pharmaceutical Co., Ltd.
    Active DMF 35906 · latest filing May 2021
    China
  • MOREPEN LABORATORIES LTD
    Active DMF 32651 · latest filing Mar 2018
    India Company GMP cert on record
  • NENTER AND CO INC
    Active DMF 36118 · latest filing Jul 2022
    United States
  • NINGBO MENOVO PHARMACEUTICAL CO LTD
    Active DMF 38661 · latest filing Aug 2023
    China
  • SHAOXING JINGXIN PHARMACEUTICALS CO LTD
    Active DMF 40400 · latest filing Sept 2024
    China
  • TAPI NL BV
    Active DMF 30830 · latest filing Dec 2016
    Netherlands
  • Zhejiang Hongyuan Pharmaceutical Co., Ltd.
    Active DMF 39218, 42171 · latest filing Dec 2025
    China Company GMP cert on record
  • ZHEJIANG NEO DANKONG PHARMACEUTICAL CO LTD
    Active DMF 20677 · latest filing Jul 2007
  • Egis Pharmaceuticals PLC
    Inactive DMF 23592 · latest filing Feb 2010
    HungaryCEP Company GMP cert on record
Need Rosuvastatin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (1)

Certificates of Suitability on the EDQM register for Rosuvastatin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 2 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
EGIS PHARMACEUTICALS PLC. Budapest XHU
CEP 2025-502 - Rev 00
Rosuvastatin zinc tetrahydrate, Process 1, form I, milled
Apr 2026Inspected Nov 2025
Hungary

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Rosuvastatin are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • Teva Pharmaceutical Industries Ltd.
    Israel · Inactive DMF 27879 · filed Feb 2014

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Rosuvastatin is a statin medication used to lower cholesterol and prevent cardiovascular disease. It works by inhibiting the enzyme HMG-CoA reductase, which plays a central role in the production of cholesterol in the liver.

Chemical identity

IUPAC name
(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid
Canonical SMILES
CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
InChIKey
BPRHUIZQVSMCRT-LBPRGKRZSA-N

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
HMG-CoA Reductase Inhibitor
Mechanism of action
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Therapeutic areas

Cardiovascular DiseasesMetabolic Disorders

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Rosuvastatin?

11 organisations hold an active US FDA Type II Drug Master File or a CEP for Rosuvastatin: ZHEJIANG LEPU PHARMACEUTICAL CO., LTD. (China), Jiangsu Alpha Group Furui Pharmaceutical (Suqian) Co., Ltd. (China), Jiangsu Alpha Pharmaceutical Co., Ltd. (China), MOREPEN LABORATORIES LTD (India), NENTER AND CO INC (United States), NINGBO MENOVO PHARMACEUTICAL CO LTD (China), SHAOXING JINGXIN PHARMACEUTICALS CO LTD (China) and TAPI NL BV (Netherlands), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Rosuvastatin Drug Master Files are active?

ZHEJIANG LEPU PHARMACEUTICAL CO., LTD. (DMF 25781, 20751), Jiangsu Alpha Group Furui Pharmaceutical (Suqian) Co., Ltd. (DMF 41439), Jiangsu Alpha Pharmaceutical Co., Ltd. (DMF 35906), MOREPEN LABORATORIES LTD (DMF 32651), NENTER AND CO INC (DMF 36118), NINGBO MENOVO PHARMACEUTICAL CO LTD (DMF 38661), SHAOXING JINGXIN PHARMACEUTICALS CO LTD (DMF 40400) and TAPI NL BV (DMF 30830) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Rosuvastatin records mean?

1 organisation has only inactive Type II DMFs for Rosuvastatin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Rosuvastatin have a European Certificate of Suitability?

Yes. 1 organisation holds a valid CEP for Rosuvastatin on the EDQM register, including EGIS PHARMACEUTICALS PLC. Budapest X (HU). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Rosuvastatin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Rosuvastatin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.